 | • レポートコード：MRC23Q36202 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の鼻除菌薬品市場について調査・分析し、世界の鼻除菌薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（鼻用ムピロシン、鼻用ポビドンヨード、その他）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Global Life Technologies、PDI Healthcare、3M、Clorox Healthcare、Medline、GSK、Teva、Glenmark Pharmsなどが含まれています。 世界の鼻除菌薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、鼻除菌薬品市場規模を推定する際に考慮しました。本レポートは、鼻除菌薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、鼻除菌薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・鼻除菌薬品市場の概要 - 鼻除菌薬品のタイプ別セグメント - 世界の鼻除菌薬品市場規模：タイプ別分析（鼻用ムピロシン、鼻用ポビドンヨード、その他） - 鼻除菌薬品の用途別セグメント - 世界の鼻除菌薬品市場規模：用途別分析（病院、薬局、その他） - 世界の鼻除菌薬品市場規模予測（2018年-2029年） ・鼻除菌薬品市場の成長トレンド - 鼻除菌薬品の地域別市場規模（2018年-2029年） - 鼻除菌薬品市場ダイナミクス - 鼻除菌薬品の業界動向 - 鼻除菌薬品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：鼻用ムピロシン、鼻用ポビドンヨード、その他 - 世界の鼻除菌薬品のタイプ別市場規模（2018年-2023年） - 世界の鼻除菌薬品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、薬局、その他 - 世界の鼻除菌薬品の用途別市場規模（2018年-2023年） - 世界の鼻除菌薬品の用途別市場規模（2024年-2029年） ・鼻除菌薬品の地域別市場規模 - 北米の鼻除菌薬品市場規模（2018年-2029年） - アメリカの鼻除菌薬品市場規模（2018年-2029年） - ヨーロッパの鼻除菌薬品市場規模（2018年-2029年） - アジア太平洋の鼻除菌薬品市場規模（2018年-2029年） - 中国の鼻除菌薬品市場規模（2018年-2029年） - 日本の鼻除菌薬品市場規模（2018年-2029年） - 韓国の鼻除菌薬品市場規模（2018年-2029年） - インドの鼻除菌薬品市場規模（2018年-2029年） - オーストラリアの鼻除菌薬品市場規模（2018年-2029年） - 中南米の鼻除菌薬品市場規模（2018年-2029年） - 中東・アフリカの鼻除菌薬品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Global Life Technologies、PDI Healthcare、3M、Clorox Healthcare、Medline、GSK、Teva、Glenmark Pharms ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Nasal Decolonization Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nasal Decolonization Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nasal Decolonization Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Nasal Decolonization Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nasal Decolonization Drug include Global Life Technologies, PDI Healthcare, 3M, Clorox Healthcare, Medline, GSK, Teva and Glenmark Pharms, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Decolonization Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Decolonization Drug.
The Nasal Decolonization Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nasal Decolonization Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nasal Decolonization Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Global Life Technologies
PDI Healthcare
3M
Clorox Healthcare
Medline
GSK
Teva
Glenmark Pharms
Segment by Type
Nasal Mupirocin
Nasal Povidone Iodine
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nasal Decolonization Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nasal Decolonization Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nasal Mupirocin
1.2.3 Nasal Povidone Iodine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nasal Decolonization Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nasal Decolonization Drug Market Perspective (2018-2029)
2.2 Nasal Decolonization Drug Growth Trends by Region
2.2.1 Global Nasal Decolonization Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nasal Decolonization Drug Historic Market Size by Region (2018-2023)
2.2.3 Nasal Decolonization Drug Forecasted Market Size by Region (2024-2029)
2.3 Nasal Decolonization Drug Market Dynamics
2.3.1 Nasal Decolonization Drug Industry Trends
2.3.2 Nasal Decolonization Drug Market Drivers
2.3.3 Nasal Decolonization Drug Market Challenges
2.3.4 Nasal Decolonization Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nasal Decolonization Drug Players by Revenue
3.1.1 Global Top Nasal Decolonization Drug Players by Revenue (2018-2023)
3.1.2 Global Nasal Decolonization Drug Revenue Market Share by Players (2018-2023)
3.2 Global Nasal Decolonization Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nasal Decolonization Drug Revenue
3.4 Global Nasal Decolonization Drug Market Concentration Ratio
3.4.1 Global Nasal Decolonization Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nasal Decolonization Drug Revenue in 2022
3.5 Nasal Decolonization Drug Key Players Head office and Area Served
3.6 Key Players Nasal Decolonization Drug Product Solution and Service
3.7 Date of Enter into Nasal Decolonization Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nasal Decolonization Drug Breakdown Data by Type
4.1 Global Nasal Decolonization Drug Historic Market Size by Type (2018-2023)
4.2 Global Nasal Decolonization Drug Forecasted Market Size by Type (2024-2029)
5 Nasal Decolonization Drug Breakdown Data by Application
5.1 Global Nasal Decolonization Drug Historic Market Size by Application (2018-2023)
5.2 Global Nasal Decolonization Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nasal Decolonization Drug Market Size (2018-2029)
6.2 North America Nasal Decolonization Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nasal Decolonization Drug Market Size by Country (2018-2023)
6.4 North America Nasal Decolonization Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nasal Decolonization Drug Market Size (2018-2029)
7.2 Europe Nasal Decolonization Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nasal Decolonization Drug Market Size by Country (2018-2023)
7.4 Europe Nasal Decolonization Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nasal Decolonization Drug Market Size (2018-2029)
8.2 Asia-Pacific Nasal Decolonization Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nasal Decolonization Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Nasal Decolonization Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nasal Decolonization Drug Market Size (2018-2029)
9.2 Latin America Nasal Decolonization Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nasal Decolonization Drug Market Size by Country (2018-2023)
9.4 Latin America Nasal Decolonization Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nasal Decolonization Drug Market Size (2018-2029)
10.2 Middle East & Africa Nasal Decolonization Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nasal Decolonization Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Nasal Decolonization Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Global Life Technologies
11.1.1 Global Life Technologies Company Detail
11.1.2 Global Life Technologies Business Overview
11.1.3 Global Life Technologies Nasal Decolonization Drug Introduction
11.1.4 Global Life Technologies Revenue in Nasal Decolonization Drug Business (2018-2023)
11.1.5 Global Life Technologies Recent Development
11.2 PDI Healthcare
11.2.1 PDI Healthcare Company Detail
11.2.2 PDI Healthcare Business Overview
11.2.3 PDI Healthcare Nasal Decolonization Drug Introduction
11.2.4 PDI Healthcare Revenue in Nasal Decolonization Drug Business (2018-2023)
11.2.5 PDI Healthcare Recent Development
11.3 3M
11.3.1 3M Company Detail
11.3.2 3M Business Overview
11.3.3 3M Nasal Decolonization Drug Introduction
11.3.4 3M Revenue in Nasal Decolonization Drug Business (2018-2023)
11.3.5 3M Recent Development
11.4 Clorox Healthcare
11.4.1 Clorox Healthcare Company Detail
11.4.2 Clorox Healthcare Business Overview
11.4.3 Clorox Healthcare Nasal Decolonization Drug Introduction
11.4.4 Clorox Healthcare Revenue in Nasal Decolonization Drug Business (2018-2023)
11.4.5 Clorox Healthcare Recent Development
11.5 Medline
11.5.1 Medline Company Detail
11.5.2 Medline Business Overview
11.5.3 Medline Nasal Decolonization Drug Introduction
11.5.4 Medline Revenue in Nasal Decolonization Drug Business (2018-2023)
11.5.5 Medline Recent Development
11.6 GSK
11.6.1 GSK Company Detail
11.6.2 GSK Business Overview
11.6.3 GSK Nasal Decolonization Drug Introduction
11.6.4 GSK Revenue in Nasal Decolonization Drug Business (2018-2023)
11.6.5 GSK Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Nasal Decolonization Drug Introduction
11.7.4 Teva Revenue in Nasal Decolonization Drug Business (2018-2023)
11.7.5 Teva Recent Development
11.8 Glenmark Pharms
11.8.1 Glenmark Pharms Company Detail
11.8.2 Glenmark Pharms Business Overview
11.8.3 Glenmark Pharms Nasal Decolonization Drug Introduction
11.8.4 Glenmark Pharms Revenue in Nasal Decolonization Drug Business (2018-2023)
11.8.5 Glenmark Pharms Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details